Can a new pill help manage weight? a First-in-Human trial begins
NCT ID NCT07089823
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This early-stage trial is testing an experimental drug called YP05002 in healthy adults aged 18 to 65. The goal is to see if the drug is safe and how the body processes it. Participants receive either the drug or a placebo, and researchers monitor for side effects and measure drug levels in the blood. This is a first step toward understanding whether YP05002 could one day help with weight management.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental drug called YP05002
- What this could lead to
- If safe and effective, YP05002 could offer a new option for weight management.
- What could go wrong
- This is an early phase 1 trial focused on safety, not weight loss. The drug may not work or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WEIGHT MANAGEMENT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nucleus Network Melbourne Clinic
Melbourne, Victoria, 3004, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily probiotic boost metabolic health and body confidence?
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Cooking classes and tailored groceries could help teens manage weight
- Could a diabetes drug protect obese Teens' hearts?
- New pill for weight and diabetes gets first human dosing test
- New daily pill could help millions shed pounds